Reinforcing effects of methamphetamine in an animal model of Attention-Deficit/Hyperactivity Disorder-the Spontaneously Hypertensive Rat

被引:0
作者
Ike dela Peña
Hyung Seok Ahn
Ji Young Choi
Chan Young Shin
Jong Hoon Ryu
Jae Hoon Cheong
机构
[1] Sahmyook University,Uimyung Research Institute for Neuroscience
[2] Konkuk University,Center for Geriatric Neuroscience Research, Institute of Biomedical Science and Technology
[3] Kyunghee University,Department of Oriental Pharmaceutical Science
来源
Behavioral and Brain Functions | / 6卷
关键词
Methamphetamine; Conditioned Place Preference; Inactive Lever; Conditioned Place Preference Test; Inactive Lever Press;
D O I
暂无
中图分类号
学科分类号
摘要
Substrains of the Spontaneously Hypertensive rat (SHR), a putative animal model of Attention-Deficit/Hyperactivity Disorder (ADHD), have demonstrated increased sensitivity to many drugs of abuse, including psychostimulants. Therefore, it was suggested that studies in SHR may help elucidate ADHD and comorbidity with substance use disorder (SUD). However, the drug intake profile of the SHR in the most relevant animal model of drug addiction, the self-administration (SA) test, and its response on the conditioned place preference (CPP) paradigm are not yet determined. In the present study, we employed SA and CPP tests to investigate the reinforcing effects of the psychostimulant methamphetamine in an SHR substrain obtained from Charles River, Japan (SHR/NCrlCrlj). Concurrent tests were also performed in Wistar rats, the strain representing "normal" heterogeneous population. To address if the presence of ADHD behaviors further increases sensitivity to the rewarding effect of methamphetamine during adolescence, a critical period for the onset of drug abuse, CPP tests were especially conducted in adolescent Wistar and SHR/NCrlCrlj. We found that the SHR/NCrlCrlj also acquired methamphetamine SA and CPP, indicating reinforcing effects of methamphetamine in this ADHD animal model. However, we did not observe increased responsiveness of the SHR/NCrlCrlj to methamphetamine in both SA and CPP assays. This indicates that the reinforcing effects of methamphetamine may be similar in strains and that the SHR/NCrlCrlj may not adequately model ADHD and increased sensitivity to methamphetamine.
引用
收藏
相关论文
共 20 条
  • [11] Methylphenidate treatment causes oxidative stress and alters energetic metabolism in an animal model of attention-deficit hyperactivity disorder
    Comim, Clarissa M.
    Gomes, Karin M.
    Reus, Gislaine Z.
    Petronilho, Fabricia
    Ferreira, Gabriela K.
    Streck, Emilio L.
    Dal-Pizzol, Felipe
    Quevedo, Joao
    ACTA NEUROPSYCHIATRICA, 2014, 26 (02): : 96 - 103
  • [12] Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology
    Sim, T
    Simon, SL
    Domier, CP
    Richardson, K
    Rawson, RA
    Ling, W
    JOURNAL OF ADDICTIVE DISEASES, 2002, 21 (01) : 75 - 89
  • [13] Childhood histories of attention-deficit hyperactivity disorders in Japanese methamphetamine and inhalant abusers: Preliminary report
    Matsumoto, T
    Kamijo, A
    Yamaguchi, A
    Iseki, E
    Hirayasu, Y
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2005, 59 (01) : 102 - 105
  • [14] Rodent models of attention-deficit hyperactivity disorder: An updated framework for model validation and therapeutic drug discovery
    Kantak, Kathleen M.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2022, 216
  • [15] Peripheral Vasculopathy Associated with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder
    Yu, Zheya Jenny
    Parker-Kotler, Caroline
    Tran, Kathleen
    Weller, Ronald A.
    Weller, Elizabeth B.
    CURRENT PSYCHIATRY REPORTS, 2010, 12 (02) : 111 - 115
  • [16] A comparison of methamphetamine-dependent inpatients with and without childhood attention deficit hyperactivity disorder symptomatology
    Jaffe, C
    Bush, KR
    Straits-Troster, K
    Meredith, C
    Romwall, L
    Rosenbaum, G
    Cherrier, M
    Saxon, AJ
    JOURNAL OF ADDICTIVE DISEASES, 2005, 24 (03) : 133 - 152
  • [17] No evidence of structural abnormality of the substantia nigra in adult attention-deficit/hyperactivity disorder: a pilot cross-sectional cohort study
    Friedrich, Isabel
    von Kuenheim, Daniela
    Wozniak, David
    Meyer, Patrick
    Mauche, Nicole
    Huang, Jue
    Classen, Joseph
    Strauss, Maria
    Rumpf, Jost-Julian
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [18] Alternative routine for reporting chiral amphetamine test results in assessment of attention-deficit/hyperactivity disorder medication: experiences from 2013 to 2023
    Helander, Anders
    Andersson, Annika
    Villen, Tomas
    DRUG TESTING AND ANALYSIS, 2025, 17 (01) : 163 - 169
  • [19] Do prescription stimulants increase risk of Parkinson's disease among adults with attention-deficit hyperactivity disorder? A retrospective cohort study
    Kindt, Hailey M.
    Tuan, Wen-Jan
    Bone, Curtis W.
    FAMILY PRACTICE, 2023, 41 (04) : 605 - 609
  • [20] Baseline-Dependent Effects of Cocaine Pre-Exposure on Impulsivity and D2/3 Receptor Availability in the Rat Striatum: Possible Relevance to the Attention-Deficit Hyperactivity Syndrome
    Caprioli, Daniele
    Hong, Young T.
    Sawiak, Stephen J.
    Ferrari, Valentina
    Williamson, David J.
    Jupp, Bianca
    Carpenter, T. Adrian
    Aigbirhio, Franklin I.
    Everitt, Barry J.
    Robbins, Trevor W.
    Fryer, Tim D.
    Dalley, Jeffrey W.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (08) : 1460 - 1471